Raelipskie Partnership Johnson & Johnson Call Options Transaction History
Raelipskie Partnership
- $205 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding JNJ
# of Institutions
4,275Shares Held
1.68BCall Options Held
17.6MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$33.4 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$28.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$19.4 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.11 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.52 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $378B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...